Feasibility study of fluorescence-guided surgery using 5-aminolevulinic acid in head and neck cancer.

Feasibility study of fluorescence-guided surgery using 5-aminolevulinic acid in head and neck cancer. - Feasibility study of fluorescence-guided surgery using 5-ALA in head and neck cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019448

Enrollment

Registered

2015-10-22

Start date

2015-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

Preoperative oral administration of 5-ALA (20 mg/kg)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of head and neck cancer with surgical indication

Exclusion criteria

Exclusion criteria: Patients with porphyria, pregnancy, severe cardiac, renal or hepatic disorders or poor general condition

Design outcomes

Primary

Measure	Time frame
The comparison of fluorescence emission and histological lesion in resected specimens	—

Secondary

Measure	Time frame
Complications Recurrence rate	—

Countries

Japan

Contacts

Public ContactShunsuke Miyamoto

Kitasato University School of Medicine Department of Otorhinolaryngology-Head and Neck Surgery

s-miya@kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026